BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2936888)

  • 21. Pathogenicity of Clostridium species with other bacteria in mixed infections.
    Brook I; Walker RI
    J Infect; 1986 Nov; 13(3):245-53. PubMed ID: 2878957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple brain abscesses and bacteremia in a child due to Fusobacterium necrophorum.
    Meis JF; Polder TW; van de Kar P; Hoogkamp-Korstanje JA
    Infection; 1993; 21(3):174-6. PubMed ID: 8365815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host response to mixed anaerobic infection with Bacteroides melaninogenicus and Fusobacterium necrophorum.
    McCallum RE; Urbaschek R; Ditter B; Urbaschek B
    Infection; 1983; 11(1):35-40. PubMed ID: 6132881
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of Escherichia coli haemolysin in the pathogenic synergy of colonic bacteria in subcutaneous abscess formation in mice.
    Ushijima T; Takahashi M; Seto A
    J Med Microbiol; 1990 Sep; 33(1):17-22. PubMed ID: 2146395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological characteristics of infections caused by Bacteroides, Prevotella and Fusobacterium species: a prospective observational study.
    Papaparaskevas J; Katsandri A; Pantazatou A; Stefanou I; Avlamis A; Legakis NJ; Tsakris A
    Anaerobe; 2011 Jun; 17(3):113-7. PubMed ID: 21664284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of a new murine model of liver abscess induced by Fusobacterium necrophorum injected into the caudal vein.
    Nagaoka K; Yanagihara K; Harada Y; Yamada K; Migiyama Y; Morinaga Y; Izumikawa K; Kakeya H; Nakashima M; Nishimura M; Kohno S
    J Med Microbiol; 2013 Nov; 62(Pt 11):1755-1759. PubMed ID: 23973984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of Fusobacterium necrophorum from bovine hepatic abscesses: biotypes, quantitation, virulence, and antibiotic susceptibility.
    Berg JN; Scanlan CM
    Am J Vet Res; 1982 Sep; 43(9):1580-6. PubMed ID: 7149404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of growth of aerobic and facultative bacteria in mixed infections with Bacteroides species.
    Brook I
    Infect Immun; 1985 Dec; 50(3):929-31. PubMed ID: 4066037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Febrile syndrome after closed abdominal trauma].
    Artero A; Camarena JJ; Jordán M; Ruiz Mf M; Vicente R; Nogueira JM
    Enferm Infecc Microbiol Clin; 2001; 19(7):343-4. PubMed ID: 11747794
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of Fusobacterium isolates from the respiratory tract of white-tailed deer (Odocoileus virginianus).
    Brooks JW; Kumar A; Narayanan S; Myers S; Brown K; Nagaraja TG; Jayarao BM
    J Vet Diagn Invest; 2014 Mar; 26(2):213-20. PubMed ID: 24590666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species.
    Brook I; Pazzaglia G; Coolbaugh JC; Walker RI
    J Antimicrob Chemother; 1983 Dec; 12(6):599-606. PubMed ID: 6363381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteroides infections in children.
    Brook I
    J Med Microbiol; 1995 Aug; 43(2):92-8. PubMed ID: 7629859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orbital abscesses caused by Fusobacterium necrophorum.
    Ralli M; Taban M; Mancini R; Goldberg RA
    Ophthalmic Plast Reconstr Surg; 2009; 25(1):70-2. PubMed ID: 19273938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimum inhibitory concentrations for selected antimicrobial agents against Fusobacterium necrophorum isolated from hepatic abscesses in cattle and sheep.
    Mateos E; Piriz S; Valle J; Hurtado M; Vadillo S
    J Vet Pharmacol Ther; 1997 Feb; 20(1):21-3. PubMed ID: 9049945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic pathogenicity of Porphyromonas gingivalis and Fusobacterium nucleatum in the mouse subcutaneous chamber model.
    Metzger Z; Lin YY; Dimeo F; Ambrose WW; Trope M; Arnold RR
    J Endod; 2009 Jan; 35(1):86-94. PubMed ID: 19084132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study.
    Centor RM; Atkinson TP; Ratliff AE; Xiao L; Crabb DM; Estrada CA; Faircloth MB; Oestreich L; Hatchett J; Khalife W; Waites KB
    Ann Intern Med; 2015 Feb; 162(4):241-7. PubMed ID: 25686164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Retrospective analysis of Fusobacterium associated infections; experience at Aomori Prefectural Hospital with 108 cases from 1995 to 1999].
    Kawamura C; Nakamura T; Watanabe K; Kaimori M
    Kansenshogaku Zasshi; 2002 Jan; 76(1):23-31. PubMed ID: 11852471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
    Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental infections with anaerobic bacteria in mice.
    Wilkins TD; Walker CB; Nitzan D; Salyers AA
    J Infect Dis; 1977 Mar; 135 Suppl():S13-7. PubMed ID: 850086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteriology of mastoid subperiosteal abscess in children.
    Migirov L; Kronenberg J
    Acta Otolaryngol; 2004 Jan; 124(1):23-5. PubMed ID: 14977073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.